C5AR2: A Potential Drug Target and Biomarker for Allergic Reactions

Target Name: C5AR2

NCBI ID: G27202

C5AR2

C5AR2: A Potential Drug Target and Biomarker for Allergic Reactions

Allergic reactions are a significant public health issue, affecting millions of people worldwide. Allergic disorders, such as allergies, asthma, and food allergies, can cause significant morbidity and mortality, as well as significant economic burden due to lost productivity and healthcare costs. The C5AR2 gene, located on chromosome 5q35, has been identified as a potential drug target and biomarker for allergic reactions.

C5AR2: Structure and Function

The C5AR2 gene encodes a protein known as C5AR2, which is a member of the superfamily of G protein-coupled receptors (GPCRs). GPCRs are a family of transmembrane proteins that play a central role in cellular signaling, including sensory perception, neurotransmission, and hormone signaling. C5AR2 is expressed in many tissues and cells, including the airways, skin, and blood vessels, and is involved in the regulation of allergic responses.

C5AR2 is a 21-kDa protein that consists of an extracellular domain, a transmembrane domain, and an intracellular domain. The extracellular domain is involved in cell adhesion and interaction, while the transmembrane domain is involved in intracellular signaling. The intracellular domain is responsible for the interaction with GPCR signaling pathways, including the regulation of cytoskeletal dynamics, cell signaling, and hormone signaling.

C5AR2 has been shown to play a role in the regulation of allergic responses, including the regulation of inflammation and the modulation of cytokine production. C5AR2 has been shown to interact with several intracellular signaling pathways, including the TGF-β pathway, the NF-kappa-B pathway, and the PI3K/AKT pathway.

C5AR2 as a Drug Target

The C5AR2 gene is a potential drug target for the treatment of allergic reactions. Currently, there are several drugs that are being developed to treat allergic reactions, including corticosteroids, leukotriene modifiers, and anti-IgE drugs. However, these drugs have several limitations, including the potential for adverse effects and limited efficacy in some patients.

C5AR2 has been shown to be a potential drug target for the treatment of allergic reactions by modulating the cytoskeleton and regulating the production of pro-inflammatory cytokines. One of the potential mechanisms by which C5AR2 may modulate cytoskeleton is through the regulation of microtubule dynamics. Microtubules are important for the regulation of cell division, and are involved in the production of pro-inflammatory cytokines.

C5AR2 has been shown to interact with the protein Tau, which is involved in the regulation of microtubule dynamics. Tau is a protein that is known to interact with several intracellular signaling pathways, including the TGF-β pathway. The TGF-β pathway is involved in the regulation of cell growth, differentiation, and inflammation, and is a potential target for the modulation of microtubule dynamics by C5AR2.

C5AR2 has also been shown to interact with the protein p120, which is involved in the regulation of actin dynamics. Actin is a protein that is involved in the regulation of cell adhesion and signaling, and is involved in the production of pro-inflammatory cytokines.

C5AR2 as a Biomarker

C5AR2 has also been shown to be a potential biomarker for the diagnosis and monitoring of allergic reactions. The C5AR2 gene has been shown to be expressed in a variety of tissues and cells, including the airways, skin, and blood vessels. This makes C5AR2 a potential biomarker for

Protein Name: Complement C5a Receptor 2

Functions: Receptor for the chemotactic and inflammatory C3a, C4a and C5a anaphylatoxin peptides and also for their dearginated forms ASP/C3adesArg, C4adesArg and C5adesArg respectively. Couples weakly to G(i)-mediated signaling pathways

The "C5AR2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C5AR2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets